Picture of BLS Pharmaceuticals logo

BXNDA BLS Pharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Bioxyne's Unit Enters Manufacturing Agreement With Remidose Latam Srl

Dec 11 (Reuters) - Bioxyne Ltd BXN.AX:

UNIT ENTERED MANUFACTURING AGREEMENT WITH REMIDOSE LATAM SRL

UNDER DEAL, BLS TO MANUFACTURE THC PASTILLE PRODUCTS FOR SUPPLY INTO MEDICINAL CANNABIS MARKETS OF COSTA RICA & PANAMA

Further company coverage: BXN.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BLS Pharmaceuticals

See all news